Legend Biotech CORP Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Legend Biotech Corp. Director Patrick John Casey reported a sale of 6,000 ordinary shares on June 30, 2026, for a total transaction value of $88,800.
NASDAQ
Form 4: Legend Biotech CEO Sells Shares
Legend Biotech Corp. CEO Ying Huang reported a sale of 5,566 ordinary shares on June 25, 2026, to cover tax obligations.
NASDAQ
Legend Biotech Corp's CEO, Huang Ying, sold 9,936 ordinary shares to cover tax obligations related to restricted share unit vesting.